Provided by Tiger Trade Technology Pte. Ltd.

KraneShares MSCI All China Health Care Index ETF

18.72
+0.08000.43%
Post-market: 18.720.00000.00%16:10 EDT
Volume:95.48K
Turnover:1.78M
Market Cap:110.43M
PE:- -
High:18.75
Open:18.74
Low:18.56
Close:18.64
52wk High:20.39
52wk Low:14.38
Shares:5.90M
Float Shares:5.90M
Volume Ratio:0.50
T/O Rate:1.62%
Dividend:0.72
Dividend Rate:3.82%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Is Akeso (SEHK:9926) Cheap As Its Phase III Colon Cancer Trial Expands Its Pipeline?

Simply Wall St.
·
Yesterday

Akeso Doses First Patient in Phase III Cadonilimab Perioperative Trial for MSI-H/dMMR Colon Cancer

Reuters
·
Oct 10

WuXi Biologics Showcases Biomanufacturing Capabilities at CPHI Milan 2026

Reuters
·
Oct 09

Innovent Announces Phase 3 Restore-3 Study of Sycume® (Teprotumumab N01 Injection) Met Primary Endpoint in Inactive Thyroid Eye Disease

THOMSON REUTERS
·
Oct 09

CSPC Pharma Presents Data from Cervical Cancer Study at Gynecologic Cancer Society Meeting

MT Newswires Live
·
Oct 08

CSPC Pharma Unveils Phase I Data for SYS6002 Monotherapy in Advanced Cervical Cancer at IGCS 2026 Rapid Oral Presentation

Stock News
·
Oct 08

CSPC Pharmaceutical Group Stock Sheds 5.4% in Hong Kong, Underperforms Competitors

Dow Jones
·
Oct 08

Hong Kong Stock Market Movers: Innovative Drug Stocks Deepen Losses in Afternoon Session, Ascletis Pharma-B (01672) Falls Over 10%, Innovent Bio (01801) Drops Nearly 4%

Stock News
·
Oct 08

Is Innovent Biologics (SEHK:1801) Undervalued After Jaypirca Approval And New IBI3003 Data?

Simply Wall St.
·
Oct 07

Wuxi Biologics (Cayman) Stock Slips 2.1% in Hong Kong

Dow Jones
·
Oct 07

How FDA Inspection Success At WuXi Biologics Stock Has Changed Its Investment Story

Simply Wall St.
·
Oct 07

CSPC Pharmaceutical Group Stock Rises 1.5% in Hong Kong, Underperforms Competitors

Dow Jones
·
Oct 06

CRO Sector Stocks Lead Afternoon Gains; WuXi Bio and Pharmaron Each Rise Over 4%

Deep News
·
Oct 06

Hong Kong Stocks Climb, Led by Pharmaceutical, Tech Stocks

Reuters
·
Oct 06

JPMorgan Unfazed by Rising Rates Impact on China Healthcare, Remains Bullish on Biotech and CXO

Stock News
·
Oct 06

Hong Kong Stock Movers: CRO Concept Stocks Lead Gains as JPMorgan Says Rate Hikes Are Not a Major Concern, Order Growth to Underpin Future Earnings

Stock News
·
Oct 06

Hong Kong Stock Movers: Innovative Drug Stocks Extend Gains as BofA Points to Three Major Recent Partnerships Strengthening Sector Momentum and ESMO Set to Bring Dense Catalysts

Stock News
·
Oct 06

CSPC Pharma to Present Updates from Eight Trials at European Oncology Conference

MT Newswires Live
·
Oct 05

CSPC Pharma to Unveil Eight New Clinical Trial Advances at 2026 ESMO Congress

Stock News
·
Oct 05

Wuxi Biologics (Cayman) Stock Advances 1.6% in Hong Kong

Dow Jones
·
Oct 05